Epidemiological trends and burden of gout in China and the European Union: a GBD 2023 and Mendelian randomization study - Top-Institutions - MDSpire

Epidemiological trends and burden of gout in China and the European Union: a GBD 2023 and Mendelian randomization study

  • By

  • Xiaolong Lyu

  • Vahid Jahed

  • Wenzheng Ding

  • Xiaolei Sun

  • Reem Jamous

  • Junwen Zheng

  • Zahra Sabouri

  • Christian Heiss

  • Houmam Anees

  • Thaqif El Khassawna

  • May 5, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    University of Oxford
    University of Oxford

    Oxford, United Kingdom

    Key Differentiators

    • Rheumatology
    • Epidemiology

  • #2

    University of Nottingham
    University of Nottingham

    Nottingham, United Kingdom

    Key Differentiators

    • Rheumatology
    • Clinical Research

  • #3

    Institute of Health Metrics and Evaluation
    Institute of Health Metrics and Evaluation

    Seattle, Washington

    Key Differentiators

    • Epidemiology
    • Public Health

Original Source(s)

Epidemiological trends and burden of gout in China and the European Union: a GBD 2023 and Mendelian randomization study

  • by Xiaolong Lyu, Vahid Jahed, Wenzheng Ding, Xiaolei Sun, Reem Jamous, Junwen Zheng, Zahra Sabouri, Christian Heiss, Houmam Anees, Thaqif El Khassawna

  • May 5, 2026

Related Content

Associations of systemic immune-inflammation index and aggregate index of systemic inflammation with acute gouty arthritis in men: a cross-sectional study

Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study

Allopurinol, gout, and cardiovascular risk